ResearcherOkayama UniversityActive in the last 2 years
Masashi Hashimoto
Matched on ORCID iD 0000-0002-0329-5110; OpenAlex author ID A5044730038. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2022: 2 papers · 2023: none · 2024: 2 papers · 2025: none · 2026: 2 papers
Papers 6
- Turning pancreatic cancer from cold to hot: the promise of a p53-expressing oncolytic adenovirus (OBP-702). Co-author DOI 10.1007/s10147-026-02991-7↗
- Multidisciplinary Treatment for Advanced Pancreatic Adenocarcinoma Arising from Esophageal Heterotopic Pancreas in a Young Adult: A Case Report. Co-author DOI 10.70352/scrj.cr.26-0088↗
- Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus. Co-author DOI 10.1038/s41416-024-02583-0↗
- Author Correction: Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus. Co-author DOI 10.1038/s41416-024-02850-0↗
- Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer. Co-author DOI 10.1016/j.omto.2022.09.003↗
- [Telomerase-Specific Oncolytic Adenovirus Expressing p53 Gene Stimulating CD8+ Memory T Cells in Pancreatic Cancer]. Co-author PMID 36281608↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Toshiyoshi Fujiwara · 6 shared papers, 2022–2026 · strength 1.21
- Paper Turning pancreatic cancer from cold to hot: the promise of a p53-expressing oncolytic adenovirus (OBP-702). DOI 10.1007/s10147-026-02991-7↗
- Paper Multidisciplinary Treatment for Advanced Pancreatic Adenocarcinoma Arising from Esophageal Heterotopic Pancreas in a Yo… DOI 10.70352/scrj.cr.26-0088↗
- Paper Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic aden… DOI 10.1038/s41416-024-02583-0↗
- Shinji Kuroda · 5 shared papers, 2022–2026 · strength 0.94
- Paper Turning pancreatic cancer from cold to hot: the promise of a p53-expressing oncolytic adenovirus (OBP-702). DOI 10.1007/s10147-026-02991-7↗
- Paper Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic aden… DOI 10.1038/s41416-024-02583-0↗
- Paper Author Correction: Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-spec… DOI 10.1038/s41416-024-02850-0↗
- Ryuichi Yoshida · 3 shared papers, 2022–2024 · strength 0.47
- Paper Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic aden… DOI 10.1038/s41416-024-02583-0↗
- Paper Author Correction: Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-spec… DOI 10.1038/s41416-024-02850-0↗
- Paper Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic… DOI 10.1016/j.omto.2022.09.003↗
- Kazuya Yasui · 2 shared papers, 2024 · strength 0.33
- Paper Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic aden… DOI 10.1038/s41416-024-02583-0↗
- Paper Author Correction: Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-spec… DOI 10.1038/s41416-024-02850-0↗
- Yohei Mizusawa · 1 shared paper, 2026 · strength 0.27
- Yoshinori Kajiwara · 1 shared paper, 2022 · strength 0.14
- Hiroyuki Araki · 1 shared paper, 2022 · strength 0.14
- Yuzo Umeda · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.